Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Gufic Biosciences Ltd

GUFICBIO.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: N/A

Last Close

$4.42

▼ -1.87%

Market Cap $443.62M · Vol 165.95K

Key Metrics

P/E Ratio

65.97

FWD: N/A

Market Cap

$443.62M

Small Cap

Div Yield

0.02%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

72.58

Momentum

Beta

0.61

vs Market

52W High

$4.69

6.53% below

52W Low

$2.81

56.03% above

Volume

165.95K

Avg 101.92K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

22.50%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Gufic Biosciences Ltd (GUFICBIO.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GUFICBIO.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.19%

+5.74%

+47.36%

+36.41%

YTD

+25.65%

+18.43%

+29.30%

+93.32%

Financials & Valuation

TTM · Annual

Total Revenue	$101.01M
Net Income	$6.87M
Revenue Growth (YoY)	+16.58%
Gross Margin	52.12%
Operating Margin	12.77%
Net Profit Margin	6.80%
ROE	N/A
ROA · ROIC	6.89% · 9.11%

P/E Ratio	65.97
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	100.28M

Technical Indicators

50-Day SMA	$4.05
200-Day SMA	$3.48
RSI (14)	72.58
Beta	0.61
52-Week High	$4.69
52-Week Low	$2.81

Volume Today	165.95K
Avg Daily Volume (30D)	101.92K
Relative Volume	1.63x
Volatility (10D)	29.59
Volatility (30D)	29.33
Free Float	22.50%

Analyst Consensus

N/A

Current Price $4.42

Mean Target N/A

52W Low$2.81 52W High$4.69

Current

Target

$2.81 $4.69

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S831W8

ISININE742B01025

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Gufic Biosciences Limited is an India-based company, which is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates in the pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.